Rani Therapeutics Holdings, Inc. Class A Common Stock (RANI)
Since Sep 13, 2021, Rani Therapeutics Holdings, Inc. Class A Common Stock (RANI) has reported earnings 19 times. On average the shares move ±6.99% post-earnings, with a positive reaction 31.6% of the time. Its largest post-earnings gain was +13.01% (May 13, 2025) and its largest decline was -25.85% (Aug 10, 2022). The next earnings report is predicted for 2026-11-10 (estimated).
Earnings reactions
How RANI moved on each past earnings report.
Earnings Impact
Total Earnings
19
Avg Abs. Movement
±6.99%
Positive %
31.6%
Negative %
68.4%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| Aug 13, 2026 | ☽ POST | +0.14% | open_in_new |
| May 15, 2026 | ☽ POST | -11.8% | open_in_new |
| Mar 26, 2026 | ☽ POST | -25.34% | open_in_new |
| Nov 06, 2025 | ☽ POST | -10.24% | open_in_new |
Earnings Count
19
Total earnings in dataset
Avg Abs. Movement
±6.99%
Avg % price change on earnings
Institutional ownership
Holdings as of Jun 30, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| SCHEDULE 13G/A | 20260814 | open_in_new SEC.gov |
| 10-Q | 20260813 | open_in_new SEC.gov |
| 8-K | 20260813 | open_in_new SEC.gov |
| 3 | 20260804 | open_in_new SEC.gov |
| 4 | 20260804 | open_in_new SEC.gov |
| 8-K | 20260804 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260731 | open_in_new SEC.gov |
| 4 | 20260723 | open_in_new SEC.gov |
| 4 | 20260721 | open_in_new SEC.gov |
| 4 | 20260721 | open_in_new SEC.gov |
Frequently asked about RANI earnings
When does Rani Therapeutics Holdings, Inc. Class A Common Stock report earnings next? expand_more
Rani Therapeutics Holdings, Inc. Class A Common Stock (RANI)'s next earnings date is estimated for 2026-11-10. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does RANI stock move after earnings? expand_more
Over 19 reports, RANI has moved an average of ±6.99% the session after earnings, closing higher 31.6% of the time.
What was RANI's biggest post-earnings move? expand_more
RANI's largest post-earnings gain on record was +13.01% on May 13, 2025, and its largest decline was -25.85% on Aug 10, 2022.
Where can I find Rani Therapeutics Holdings, Inc. Class A Common Stock's SEC filings? expand_more
All of Rani Therapeutics Holdings, Inc. Class A Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right